跳至主要内容
临床试验/JPRN-UMIN000010353
JPRN-UMIN000010353已完成未知

An open label,randomized control study for the comparison of pliotropic effects between Glulisine and Glargine with type 2 diabetes - An open label,randomized control study for the comparison of pliotropic effects between Glulisine and Glargine with type 2 diabetes

Department of Disease Control and Homeostasis,kanazawa University Graduate School of Medical Science.0 个研究点目标入组 40 人开始时间: 2014年3月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Hypersensitivity to components of the insulin glargine and insulin glulisine. 2.None Type 2 diabetes 3.Medical history and/or complication of diabetic ketoacidosis. 4.Medical history and/or complication of severe hypoglycemia. 5.severe infection, around surgery or severe trauma. 6.Patients who received the administration of insulin, DPP-4 inhibitors or GLP-1 analog formulation within 4 weeks. 7.Treatment with glucocorticoid. 8.Uncontrolled Hypertension(systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg) 9.Proliferative retinopathy or maculopathy. 10.History of malignancy. 11.Severe health problems not suitable for the study. 12.Patients participated in other clinical trials within one month before the study. 13.Cases that Physicians deem inappropriate as the target of the test.

研究者

发起方
Department of Disease Control and Homeostasis,kanazawa University Graduate School of Medical Science.

相似试验

An open label,randomized control study for the... | 临床试验